Taiwan News2 天
Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
Jan. 29, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, and Steve Perrin, Ph.D., Chief ...